Funding for CEPI 2.0's next five-year business cycle 2022-2027

Grant number: 226066/Z/22/Z

Grant search

Key facts

  • Disease

    Disease X
  • Start & end year

    2023
    2028
  • Known Financial Commitments (USD)

    $134,241,291.6
  • Funder

    Wellcome Trust
  • Principal Investigator

    Dr. Richard Jones Hatchett IV
  • Research Location

    Norway
  • Lead Research Institution

    Coalition for Epidemic Preparedness Innovations (CEPI)
  • Research Priority Alignment

    N/A
  • Research Category

    Health Systems Research

  • Research Subcategory

    Medicines, vaccines & other technologies

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

CEPI's 2022-2027 strategic priorities are founded on the three pillars of Prepare, Transform and Connect. CEPI will prepare for known epidemics and pandemic threats by developing vaccines and promising biologics against the most prominent known threats, building on COVID-19 achievements and CEPI 1.0. CEPI will transform the response to the next novel threat by harnessing innovations in technology and systems to significantly reduce the global vulnerability to threats from novel pathogen outbreaks. CEPI will enhance and expand global collaboration by connecting emerging infectious disease stakeholders to enable rapid countermeasure development, effective response and equitable access for those in need. If the products developed with CEPI's funding are to realise their potential, they should flow through a system with pre-agreed governance, financing, allocation, and distribution mechanisms to govern their ultimate use. CEPI is already contributing to and helping shape a post-pandemic consensus, creating a well-prepared ecosystem able to react quickly without leaving anyone behind.